Keywords: high-flux haemodialysis; human recombinant erythropoietin; peripheral polyneuropathy; vitBackground. High-flux haemodialysis ( HD) has recently been vigorously promoted as a novel standard, amin B 6 and it can indeed efficiently reduce the occurrence of most uraemic symptoms due to middle molecular toxins and/or underdialysis. However, some symptoms
Introduction
remain problematical, particularly peripheral polyneuropathy (PPN ). One of the possible reasons for this is that the patients may have low concentrations of some In the early years of haemodialysis (HD), patients on nutrients, e.g. vitamin B 6 , necessary for normal peri-standard HD treatment commonly suffered from pheral neuron function.
uraemic peripheral polyneuropathy (PPN ), e.g. restless Methods. Predialysis serum pyridoxal-5∞-phosphate leg syndrome and burning foot syndrome. It was (P5P) level was determined in 36 chronic HD patients assumed that this was because of underdialysis and/or who were undergoing high-flux HD and receiving poor clearance of uraemic toxins of middle to high human recombinant erythropoietin. Among them, 26 molecular weights [1, 2] . In fact, more effective removal patients suffered from PPN. Prior to supplementation, of middle-sized and larger molecules by haemodiafiltrthese 26 patients were examined and their neurological ation did prevent the worsening of uraemic PPN during symptoms were ranked according to our PPN symptom standard HD treatment [1] . Recently, high-flux HD score. Vitamin B 6
(60 mg/day) was randomly pre-has supplanted regular HD as the standard treatment, scribed to 14 of them, and vitamin B 12
(500 mg/day) and yields better clearance of not only low-molecularwas prescribed to the others. After 4 weeks, all the weight solutes but also middle-sized molecules [3, 4] . patients were re-examined.
However, the incidence of PPN does not seem to have Results. We found that predialysis serum P5P levels of been lowered as a result. This may be explained by the HD patients with PPN were not significantly lower fact that not only pure uraemic PPN, but also a variety than those of matched HD patients without PPN. of other aetiological factors, i.e. diabetic PPN, dialysisNonetheless, it was demonstrated that supplementation related amyloidosis, or arteriosclerotic obliteration, with vitamin B 6 for 4 weeks significantly increased the may cause or aggravate numbness of the extremities predialysis level of P5P and dramatically attenuated in chronic HD patients [5, 6 ] . Additionally, another PPN symptoms compared with initial symptoms. No possible explanation may be a depletion of thus far improvement was observed in response to vitamin B 12 unrecognized members of B-complex vitamins [7] . supplementation.
Among these, vitamin B 6 is metabolized to the active Conclusion. This result suggests that although vitamin molecule, pyridoxal-5∞-phosphate (P5P), which influ-B 6 deficiency could not be demonstrated in patients ences amino acids, protein and lipid metabolism with chronic renal failure on high-flux HD, . Removal of P5P by standard HD has been supplementation was effective in improving PPN symp-extensively studied but with contradictory results toms of various aetiologies, possibly because of vitamin [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Kasama et al. [23] reported that high-flux B 6 resistance to PPN in these patients. HD depletes vitamin B 6 at a rate possibly great enough to cause vitamin B 6 deficiency. Furthermore, administration of human recombinant erythropoietin (rHuEpo), which has dramatically improved haema-Vitamin B 6 and HD-related neuropathy 1411 patients studied were divided randomly into two groups, one evidence has shown that much more vitamin B 6 is of which received the vitamin B 6 supplement (60 mg/day) consumed by haemoglobin synthesis during rHuEpo (G-VB 6 ; n=14) and the other was given the vitamin B 12 treatment in HD patients, and this may contribute to supplement (500 mg/day) (G-VB 12 ; n=12). Vitamin B 12 was vitamin B 6 deficiency [21, 24] . In the present study, we used because it is also considered to be a neurotrophic examined whether alterations in vitamin B 6 metabolism vitamin. Patients were blinded as to which medication they have any impact on symptoms of PPN in chronic renal received. The doses of vitamin B
6
and vitamin B 12 were failure patients receiving high-flux HD and rHuEpo chosen based on recommendations for HD patients treated treatment.
with isoniazid (INH ) and for patients with uraemic and diabetic PPN respectively [27, 28] . Four weeks later they were re-examined by HO and KM.
Subjects and methods
Ten control patients (G-Cont) receiving high-flux HD and rHuEpo treatment but without PPN symptoms were selected and evaluated. Data are shown as mean±SE. Data were Table 1 summarizes the demographic profile of the patients analysed using analysis of variance; changes in PPN symptom receiving chronic high-flux HD and rHuEpo treatment in scores were evaluated with a non-parametric statistical anathis study. Patients were selected from the Kidney Disease lysis, the Mann-Whitney U-test. P<0.05 was required for Center of Saitama Medical College and its affiliated dialysis significance. clinics. For inclusion in the study, the patients must have been on HD for at least 3 months with a constant HD prescription ( Kt/V>1.1) using high-flux, high-performance Results dialysers, and treated with rHuEpo (Epogin; Sankyo, Tokyo, Japan) 4500-9000 U/wk to maintain a haematocrit between 28 and 33%. Patients who met inclusion criteria were enrolled Table 1 shows the demographic data of each group; in the study if they complained of PPN symptoms in the there were no significant differences between these lower extremities and wished to take medication. Patients groups. Notably, there was a tendency for predialysis with clinically or angiographically identified arteriosclerotic level of P5P to be lower in G-VB 6 and G-VB 12 than obliteration, megaloblastic anaemia, any systemic illness in G-Cont, but this failed to reach statistical significcausing malnutrition and/or poor appetite, or those taking ance. Figures 1 and 2 prior to participation in the study.
The hollow-fibre dialysis membranes used in this that supplementation with vitamin B 6 , but not with study were FB-150F (Nipro, Osaka, Japan) (triacetate, vitamin B 12
, significantly reduced the PPN symptoms 1.5 m2, ultrafiltration rate ( UFR) 39.72 ml/mmHg/h, in chronic renal failure patients with high-flux HD and vitamin B 12 clearance 140 ml/min), TFW15 (Teijin-Gambro, rHuEpo treatment ( Figures 1, 2) . Of interest, PPN Tokyo, Japan) (triacetate, 1.5 m2, UFR 22 ml/mmHg/h, symptoms of diabetes mellitus (DM ) patients in G-VB 6 vitamin B 12
clearance 140 ml/min),. PS-1.6N (Fresenius-were also improved similarly to the ones of chronic Kawasumi, Tokyo, Japan) (polysulphone, 1.6 m2, UFR glomerulonephritis (CGN ) patients (Figure 1 ).
ml/mmHg/h, vitamin B 12
clearance 128 ml/min), and FLX-15GW (Nikkiso, Tokyo, Japan) (polyether polymer alloy, 1.5 m2, UFR 39 ml/mmHg/h, vitamin B 12 clearance Discussion 150 ml/min). None was re-used. Standard HD modalities in our unit are as follows: dialysis duration, 4 h; blood flow Deficiency of vitamin B 6 in humans leads to seborrate, 200 ml/min; and dialysate flow rate, 500 ml/min.
Routine heparinization was carried out as anticoagulation rhoea-like lesions, cheilosis and glossitis, depressed to keep activated coagulation time at 150 s.
lymphocyte counts, hypochromic anaemia and loss of All patients were examined and ranked according to the the ability to convert tryptophan to nicotinic acid, and PPN symptom score by HO and KM when they complained PPN [9] [10] [11] . Vitamin B 6 is rapidly converted by the of PPN symptoms in the lower extremities. The scoring body into P5P and pyridosamine phosphate, which scheme was: function as coenzymes and play an essential role in 0, no symptoms; amino acid metabolism [9] [10] [11] . Good sources of vit- The involvement of large myelinated sensory fibres in it is difficult to induce clinical signs and symptoms of uraemic neuropathy has been demonstrated using electro-vitamin B 6 deficiency by dietary restriction. However, physiological tests [25] , but in this study the results of such biochemical abnormalities indicative of subclinical vittests were not included because the PPN symptoms evaluated amin B 6 deficiency have been reported in certain groups in this study, typically in a stocking and glove distribution, of persons including uraemic patients [8, 13] . Vitamin are derived mostly from small sensory fibres [25] . Predialysis B 6 deficiency-related PPN was characterized by symblood samples were obtained at the first session of the week metrical numbness in a stocking and glove distribution, to determine routine laboratory data as well as to see the more severe in the feet than in the hands [9, 11] taking INH revealed that INH-induced PPN is due to a vitamin B 6 deficiency or a competitive inhibition of its action mediated by the formation of pyridoxal isonicotinyl hydrazone [11] .
There is also a great similarity between vitamin B 6 deficiency-related PPN and PPN in chronic HD patients. For that reason, we carried out the present study. Vitamin B 6 levels in HD patients have been extensively studied, but the results are divergent and confusing [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] 29] . Among them, Descombes et al. [29] and Kasama et al. [23] demonstrated increased clearance of P5P by high-flux HD (173±90 ml/min), and showed that P5P levels were lower in patients on high-flux HD than on standard HD. In fact, in this study, the predialysis P5P level of 7.1±1.0 ng/ml was lowered to the post-dialysis level of 3.7±0.4 ng/ml by high-flux HD in G-Cont. Additionally, Mydlik et al. [21, 24] rent preferred prescription for HD, i.e. high-flux HD and rHuEpo administration, may result in vitamin B 6 deficiency more frequently than hitherto suspected. However, in this study, the predialysis levels of serum P5P prior to the supplementation in G-VB 6 , G-VB 12 and G-Cont, which were presumed to be peak concentrations, were not significantly different, and stayed within the normal range.
Nonetheless, vitamin B 6 supplementation increased the predialysis level of P5P significantly and did improve PPN symptoms of these patients. This observation suggests the notion that perhaps even patients on high-flux HD and rHuEpo treatment are in danger of vitamin B 6 resistance to PPN. This issue has been discussed previously with respect to folic acid resistance to hyperhomocysteinaemia in patients with chronic renal failure [30, 31] . It is difficult to explain why some patients suffered from vitamin B 6 resistance, but others Fig. 2 . Changes in PPN symptom score in HD patients before and did not.
after vitamin B 12 supplementation. There was no significant change As discussed earlier, the aetiology of PPN in chronic of PPN symptom score in this group after vitamin B
